ArticleMagnetic resonance in medicine2025
WALINET: A water and lipid identification convolutional neural network for nuisance signal removal in
Article in Magnetic resonance in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Advanced methods in deuterium metabolic imaging.Magma (New York, N.Y.) · 2026Review
- WALINET: A water and lipid identification convolutional neural network for nuisance signal removal inMagnetic resonance in medicine · 2025Article
- Deep-ER: Deep Learning ECCENTRIC Reconstruction for fast high-resolution neurometabolic imaging.NeuroImage · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeProton magnetic resonance spectroscopic imaging (
methodsWe introduce a deep learning method based on a modified Y-NET network for water and lipid removal in whole-brain
resultsWALINET is significantly faster and needs 8s for high-resolution whole-brain MRSI, compared with 42min for conventional HLSVD+L2. WALINET suppresses lipid and water in the brain by 25-45 and 34-53-fold, respectively. WALINET has better performance than HLSVD+L2, providing: (1) more lipid removal with 41% lower NRMSE; (2) better metabolite signal preservation with 71% lower NRMSE in simulated data; 155% higher SNR and 50% lower CRLB in in vivo data. Metabolic maps obtained by WALINET in healthy subjects and patients show better gray-/white-matter contrast with more visible structural details.
conclusionsWALINET has superior performance for nuisance signal removal and metabolite quantification on whole-brain
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.